CoChat

Structural insights into context-specific inhibition of bacterial translation by macrolides

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

The ribosome's peptidyl transferase center (PTC) catalyzes peptide bond formation during protein synthesis and is targeted by many antibiotic classes. Remarkably, macrolides that bind in the peptide exit tunnel some ~10 Å away from the PTC also remotely inhibit PTC and cause translational arrest depending on the synthesized polypeptide sequence. The Arg/Lys-X-Arg/Lys (also known as +X+) motif is particularly susceptible to this inhibition, as peptidyl-tRNA carrying nascent peptide with penultimate arginine or lysine residue fails to react with aminoacyl-tRNA carrying the same amino acids in the presence of macrolides. While structural studies of macrolide-bound ribosomes have shed light on the context-specific nature of this inhibition, the precise roles of the drug, ribosome, and tRNA in modulating PTC activity remain unclear. In this study, we present a detailed structural analysis of ribosome-nascent chain complexes (RNCs) that represent either arrested or non-arrested states, containing various combinations of peptidyl- and aminoacyl-tRNAs, with or without macrolides. Our findings reveal a dynamic interaction between the ribosome-bound drug, the nascent peptide, and the incoming amino acid, which collectively modulates PTC function. This lays the foundation for designing antibiotics that can overcome drug resistance by preventing the induction of inducible erm genes in pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-025-64692-5

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Context-specificity of macrolide action. a Normal progression of the translating ribosome through +X+ motifs (or any other sequences) in the absence of a macrolide. Peptide bond formation in the PTC occurs normally (black arrow). b Macrolide-induced inhibition of peptide bond formation in the PTC of a ribosome progressing through +X+ sequence (red cross). Note that NPET-bound macrolide (red) is too far to establish direct contact with the incoming Arg/Lys residues (yellow) in the A site. Reproduced/modified from Aleksandrova et al., Mechanism of release factor-mediated peptidyl-tRNA hydrolysis on the ribosome, 10.1126/science.ads9030, 2025, AAAS.
Fig. 1 Context-specificity of macrolide action. a Normal progression of the translating ribosome through +X+ motifs (or any other sequences) in the absence of a macrolide. Peptide bond formation in the PTC occurs normally (black arrow). b Macrolide-induced inhibition of peptide bond formation in the PTC of a ribosome progressing through +X+ sequence (red cross). Note that NPET-bound macrolide (red) is too far to establish direct contact with the incoming Arg/Lys residues (yellow) in the A site. Reproduced/modified from Aleksandrova et al., Mechanism of release factor-mediated peptidyl-tRNA hydrolysis on the ribosome, 10.1126/science.ads9030, 2025, AAAS.CC BY-NC-ND · PubMed Central
Fig. 2 Structure of the erythromycin-arrested RNC assembled from purified components. a Overview of the structure of the T. thermophilus 70S ribosome in complex with erythromycin (ERY, red) and also containing non-hydrolyzable lysyl-tRNALys and fMRC-peptidyl-tRNAiMet in the A and P sites, respectively. The 30S subunit is shown in light yellow, the 50S subunit is in light blue, the mRNA is in blue, and the A- and P-site substrates are colored green and dark blue, respectively. The tripeptidyl moiety of the P-site tRNA is highlighted in yellow. b 2Fo-Fc electron density map (blue mesh) of the ribosome-bound ERY, aminoacyl- and peptidyl-tRNAs in the ribosomal A and P sites, respectively. The refined models of the drug and tRNAs are displayed in their respective electron density maps contoured at 1.0 σ. The entire bodies of the A- and P-site tRNAs are viewed from the back of the 50S subunit. Ribosome subunits are omitted for clarity. c, d Close-up views of the A- and P-site tRNA’s CCA-ends (c) and the ribosome-bound ERY (d) interacting with nucleotides of the 23S rRNA (blue). H-bonds are shown by black dotted lines. e, f Close-up views of the tRNAs in the PTC viewed from two different angles, highlighting the characteristic intercalation of the side chain of lysine into the A-site cleft formed by nucleotides A2451 and C2452 of the 23S rRNA (E. coli numbering of the rRNA nucleotides is used throughout). Note that −1 Arg of the P-site fMRC-peptidyl-tRNA adopts a conformation that blocks productive accommodation of the lysine residue into the A site.
Fig. 2 Structure of the erythromycin-arrested RNC assembled from purified components. a Overview of the structure of the T. thermophilus 70S ribosome in complex with erythromycin (ERY, red) and also containing non-hydrolyzable lysyl-tRNALys and fMRC-peptidyl-tRNAiMet in the A and P sites, respectively. The 30S subunit is shown in light yellow, the 50S subunit is in light blue, the mRNA is in blue, and the A- and P-site substrates are colored green and dark blue, respectively. The tripeptidyl moiety of the P-site tRNA is highlighted in yellow. b 2Fo-Fc electron density map (blue mesh) of the ribosome-bound ERY, aminoacyl- and peptidyl-tRNAs in the ribosomal A and P sites, respectively. The refined models of the drug and tRNAs are displayed in their respective electron density maps contoured at 1.0 σ. The entire bodies of the A- and P-site tRNAs are viewed from the back of the 50S subunit. Ribosome subunits are omitted for clarity. c, d Close-up views of the A- and P-site tRNA’s CCA-ends (c) and the ribosome-bound ERY (d) interacting with nucleotides of the 23S rRNA (blue). H-bonds are shown by black dotted lines. e, f Close-up views of the tRNAs in the PTC viewed from two different angles, highlighting the characteristic intercalation of the side chain of lysine into the A-site cleft formed by nucleotides A2451 and C2452 of the 23S rRNA (E. coli numbering of the rRNA nucleotides is used throughout). Note that −1 Arg of the P-site fMRC-peptidyl-tRNA adopts a conformation that blocks productive accommodation of the lysine residue into the A site.CC BY-NC-ND · PubMed Central
Fig. 3 Structure of non-arrested drug-free RNC. a, b Close-up views of the 2Fo-Fc electron density map (blue mesh) of the CCA-ends of Lys-tRNALys (teal) and fMRC-peptidyl-tRNAiMet (violet with tripeptidyl moiety highlighted in orange) in the A and P sites, respectively. The refined models of the tRNAs and 23S rRNA nucleotides (blue) are displayed in their respective electron density maps contoured at 1.0σ. H-bonds are shown by black dotted lines. c, d Superpositions of this new structure of non-arrested macrolide-free RNC with the previous structure of non-arrested 70S ribosome containing A-site Phe-tRNAPhe (greencyan) and the same P-site fMRC-peptidyl-tRNAiMet (light blue with tripeptidyl moiety highlighted in salmon) (c, PDB entry 8CVK29) or the new structure of arrested RNC containing macrolide ERY (crimson) and the same A- and P-site tRNAs (d). Note that, in the absence of NPET-bound macrolide, the side chain of the −1 Arg residue extends away from the A-site cleft and into the NPET, where it interacts with the 23S rRNA. Also, note that desosamine moiety of macrolide clashes with the side chain of −1 Arg, causing its reorientation into the A site, where it interferes with lysine accommodation.
Fig. 3 Structure of non-arrested drug-free RNC. a, b Close-up views of the 2Fo-Fc electron density map (blue mesh) of the CCA-ends of Lys-tRNALys (teal) and fMRC-peptidyl-tRNAiMet (violet with tripeptidyl moiety highlighted in orange) in the A and P sites, respectively. The refined models of the tRNAs and 23S rRNA nucleotides (blue) are displayed in their respective electron density maps contoured at 1.0σ. H-bonds are shown by black dotted lines. c, d Superpositions of this new structure of non-arrested macrolide-free RNC with the previous structure of non-arrested 70S ribosome containing A-site Phe-tRNAPhe (greencyan) and the same P-site fMRC-peptidyl-tRNAiMet (light blue with tripeptidyl moiety highlighted in salmon) (c, PDB entry 8CVK29) or the new structure of arrested RNC containing macrolide ERY (crimson) and the same A- and P-site tRNAs (d). Note that, in the absence of NPET-bound macrolide, the side chain of the −1 Arg residue extends away from the A-site cleft and into the NPET, where it interacts with the 23S rRNA. Also, note that desosamine moiety of macrolide clashes with the side chain of −1 Arg, causing its reorientation into the A site, where it interferes with lysine accommodation.CC BY-NC-ND · PubMed Central
Fig. 4 In silico modeling of Lys, Trp, or Met residues in the penultimate position of the fMRC-peptidyl-tRNA. Structural models of −1 Lys (a), −1 Trp (b), and −1 Met (c) were generated using the new structure of non-arrested drug-free RNC as a template, with additional reference to other available structures, including the structure with −1 phenylalanine38. Note that the desosamine moiety of the macrolide sterically interferes with lysine and bulky aromatic residues (such as tryptophan) in the penultimate position of the nascent chain but not with smaller side chains like methionine.
Fig. 4 In silico modeling of Lys, Trp, or Met residues in the penultimate position of the fMRC-peptidyl-tRNA. Structural models of −1 Lys (a), −1 Trp (b), and −1 Met (c) were generated using the new structure of non-arrested drug-free RNC as a template, with additional reference to other available structures, including the structure with −1 phenylalanine38. Note that the desosamine moiety of the macrolide sterically interferes with lysine and bulky aromatic residues (such as tryptophan) in the penultimate position of the nascent chain but not with smaller side chains like methionine.CC BY-NC-ND · PubMed Central
Fig. 5 Structure of non-arrested RNC with penultimate arginine mutated to alanine. a, b Close-up views of the 2Fo-Fc electron density map (blue mesh) of the ribosome-bound ERY (magenta) and the CCA-ends of Lys-tRNALys (teal) and mutated fMAC-peptidyl-tRNAiMet (violet with tripeptidyl moiety highlighted in orange) in the A and P sites, respectively. The refined models of the drug and tRNAs are displayed within their respective electron density maps contoured at 1.0σ. c, d Structural alignments comparing this new non-arrested macrolide-bound RNC with previously reported structures. c Superimposition with the non-arrested 70S ribosome containing A-site Phe-tRNAPhe (greencyan) and P-site fMRC-peptidyl-tRNAiMet (light blue, with the tripeptidyl moiety in salmon) (PDB entry 8CVK29). d Comparison with the new structure of arrested RNC containing ERY (crimson). Note that the absence of the −1 Arg residue removes steric hindrance, allowing both macrolide binding and proper accommodation of lysyl-tRNA into the PTC.
Fig. 5 Structure of non-arrested RNC with penultimate arginine mutated to alanine. a, b Close-up views of the 2Fo-Fc electron density map (blue mesh) of the ribosome-bound ERY (magenta) and the CCA-ends of Lys-tRNALys (teal) and mutated fMAC-peptidyl-tRNAiMet (violet with tripeptidyl moiety highlighted in orange) in the A and P sites, respectively. The refined models of the drug and tRNAs are displayed within their respective electron density maps contoured at 1.0σ. c, d Structural alignments comparing this new non-arrested macrolide-bound RNC with previously reported structures. c Superimposition with the non-arrested 70S ribosome containing A-site Phe-tRNAPhe (greencyan) and P-site fMRC-peptidyl-tRNAiMet (light blue, with the tripeptidyl moiety in salmon) (PDB entry 8CVK29). d Comparison with the new structure of arrested RNC containing ERY (crimson). Note that the absence of the −1 Arg residue removes steric hindrance, allowing both macrolide binding and proper accommodation of lysyl-tRNA into the PTC.CC BY-NC-ND · PubMed Central
Fig. 6 Structural analysis of non-arrested RNCs with modified A-site substrates. a−d Close-up views of the 2Fo-Fc electron density map (blue mesh) of the macrolide binding site and the CCA-ends of the P-site fMRC-peptidyl-tRNAiMet (blue/slate with tripeptidyl moiety highlighted in salmon/pink) and either aminoacylated Phe-tRNAPhe (a, b, greencyan) or deacylated tRNAPhe (c, d dark green) in the A site. In panel a, the lack of macrolide binding is highlighted by a faint contour. In panels (c, d) ribosome-bound ERY is shown in magenta. The refined models of the drug and tRNAs are displayed within their respective electron density maps contoured at 1.0 σ.) e Superimposition of the structures of the new non-arrested macrolide-bound RNC with deacylated tRNA in the A-site with arrested RNC containing ERY (crimson). Note that macrolide binding in the NPET repositions the −1 Arg residue of the nascent chain towards the A site. f Structural comparison between two non-arrested RNCs with either aminoacylated or deacylated tRNAPhe in the A site. Note that the accommodation of +1 Phe and the subsequent rearrangement of −1 Arg lead to a steric clash with the macrolide, resulting in its displacement from the ribosomal tunnel.
Fig. 6 Structural analysis of non-arrested RNCs with modified A-site substrates. a−d Close-up views of the 2Fo-Fc electron density map (blue mesh) of the macrolide binding site and the CCA-ends of the P-site fMRC-peptidyl-tRNAiMet (blue/slate with tripeptidyl moiety highlighted in salmon/pink) and either aminoacylated Phe-tRNAPhe (a, b, greencyan) or deacylated tRNAPhe (c, d dark green) in the A site. In panel a, the lack of macrolide binding is highlighted by a faint contour. In panels (c, d) ribosome-bound ERY is shown in magenta. The refined models of the drug and tRNAs are displayed within their respective electron density maps contoured at 1.0 σ.) e Superimposition of the structures of the new non-arrested macrolide-bound RNC with deacylated tRNA in the A-site with arrested RNC containing ERY (crimson). Note that macrolide binding in the NPET repositions the −1 Arg residue of the nascent chain towards the A site. f Structural comparison between two non-arrested RNCs with either aminoacylated or deacylated tRNAPhe in the A site. Note that the accommodation of +1 Phe and the subsequent rearrangement of −1 Arg lead to a steric clash with the macrolide, resulting in its displacement from the ribosomal tunnel.CC BY-NC-ND · PubMed Central
Fig. 7 Mechanism of macrolide-induced ribosome stalling at the +X+ motifs. a−i Schematic diagram illustrating the outcomes of different combinations of −1 and +1 amino acid residues present in the PTC together with macrolide antibiotics. The macrolide (red), the penultimate (−1) residue of the nascent peptide chain (orange for the PTC position of this residue, blue for NPET position), and the incoming (+1) amino acid (orange for stalled ribosome complexes, yellow for non-stalled) are highlighted. a Stalling conditions. Ribosome stalling on +X+ motifs occurs when macrolide-induced conformation of the −1 Arg/Lys residue of the growing polypeptide chain sterically hinders productive accommodation of the +1 Arg/Lys residue into the A site, making peptide bond formation impossible. b-i Non-stalling conditions. Several alternative −1 and +1 residue combinations allow translation to proceed: (b) when the −1 residue of the nascent peptide is Arg/Lys and the +1 residue contains a bulky aromatic side chain or (c−h) if the −1 residue is bulky aromatic, translation continues regardless of the identity of the +1 residue, as macrolides are displaced, and aminoacyl-tRNA successfully accommodates into the A site; (e−g) when the −1 residue lacks a large side chain (i.e., residues other than Arg/Lys/Trp/Tyr/Phe/His), there is no steric clash with the macrolide or the A-site tRNA, allowing normal peptide bond formation; (i) similarly, if the +1 residue is small, steric hindrance is minimized, and translation proceeds unimpeded. This diagram shows how the interplay between ribosome-bound macrolide (red), the −1 (orange or blue), and +1 (yellow) residues determines ribosome stalling at the +X+ motifs. Adapted from Syroegin et al., Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol, Nature Structural & Molecular Biology, 29(2):152−161, 2022, Springer Nature. Reproduced/modified with permission from Springer Nature.
Fig. 7 Mechanism of macrolide-induced ribosome stalling at the +X+ motifs. a−i Schematic diagram illustrating the outcomes of different combinations of −1 and +1 amino acid residues present in the PTC together with macrolide antibiotics. The macrolide (red), the penultimate (−1) residue of the nascent peptide chain (orange for the PTC position of this residue, blue for NPET position), and the incoming (+1) amino acid (orange for stalled ribosome complexes, yellow for non-stalled) are highlighted. a Stalling conditions. Ribosome stalling on +X+ motifs occurs when macrolide-induced conformation of the −1 Arg/Lys residue of the growing polypeptide chain sterically hinders productive accommodation of the +1 Arg/Lys residue into the A site, making peptide bond formation impossible. b-i Non-stalling conditions. Several alternative −1 and +1 residue combinations allow translation to proceed: (b) when the −1 residue of the nascent peptide is Arg/Lys and the +1 residue contains a bulky aromatic side chain or (c−h) if the −1 residue is bulky aromatic, translation continues regardless of the identity of the +1 residue, as macrolides are displaced, and aminoacyl-tRNA successfully accommodates into the A site; (e−g) when the −1 residue lacks a large side chain (i.e., residues other than Arg/Lys/Trp/Tyr/Phe/His), there is no steric clash with the macrolide or the A-site tRNA, allowing normal peptide bond formation; (i) similarly, if the +1 residue is small, steric hindrance is minimized, and translation proceeds unimpeded. This diagram shows how the interplay between ribosome-bound macrolide (red), the −1 (orange or blue), and +1 (yellow) residues determines ribosome stalling at the +X+ motifs. Adapted from Syroegin et al., Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol, Nature Structural & Molecular Biology, 29(2):152−161, 2022, Springer Nature. Reproduced/modified with permission from Springer Nature.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 8

Metadata

Authors
Syroegin, E. A., Aleksandrova, E. V., Kruglov, A. A., Paranjpe, M. N., Svetlov, M. S., & Polikanov, Y. S.
Affiliations
University of Illinois Chicago (US)
Corresponding author
  • Svetlov, Maxim S.
  • Polikanov, Yury S.
Venue
Nature Communications
Published
2025-11-03
Volume
16
Issue
1
Pages
9685-9685
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4415807405
Cited by
8
References
55
Citations by year
2026: 7 · 2025: 1
FWCI
2.40
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01-GM132302, R35-GM151957)
  • National Science Foundation (MCB-2345351)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
macrolides, peptidyl transferase center, ribosome-nascent chain complex, translational arrest, nascent polypeptide chains, peptidyl-tRNA, aminoacyl-tRNA, antibiotic resistance, ribosome structure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural insights into context-specific inhibition of bacterial translation by macrolides. https://app.cochat.ai/papers/10.1038/s41467-025-64692-5
The paper
Syroegin, E. A., Aleksandrova, E. V., Kruglov, A. A., Paranjpe, M. N., Svetlov, M. S., & Polikanov, Y. S. (2025). Structural insights into context-specific inhibition of bacterial translation by macrolides. Nature Communications. https://doi.org/10.1038/s41467-025-64692-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.